skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines tafasitamabQuestion & answer

tafasitamab · Medicine question

Which antigen on B cells does tafasitamab target?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Tafasitamab targets the CD19 antigen expressed on the surface of pre-B and mature B lymphocytes.

Sources for this answer

MINJUVI 200 mg powder for concentrate for solution for infusionIncyte Biosciences UK Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 13Document updated 9 July 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

tafasitamab

More questions about tafasitamab

Can Minjuvi (tafasitamab) affect driving or the use of machines?How long is effective contraception recommended after tafasitamab treatment ends?How much sodium and polysorbate 20 does each vial of Minjuvi (tafasitamab) contain?Is tafasitamab recommended during pregnancy?What are the breastfeeding restrictions during and after tafasitamab treatment?What symptoms can indicate an infusion-related reaction to tafasitamab within 24 hours of infusion?

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the tafasitamab guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX